Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.

Item
http://www.wikidata.org/entity/Q33521596
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerIs second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer.Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient.Outcomes of second-line chemotherapy for advanced non-small cell lung cancer in one institution.Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric CancerRefining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients.Retrospective analysis of the clinical and demographic variables on the outcomes after second-line treatment in advanced non-small cell lung cancer.Surveillance of resected non-small cell lung cancer.Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.Decision support systems for incurable non-small cell lung cancer: a systematic reviewLung cancer prognosis: can histological patterns and morphological features have a role in the management of lung cancer patients?A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival.Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
P2860

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.

Item
http://www.wikidata.org/entity/Q33521596
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Clinical assessment of patient ...... ata of nine randomised trials.
@ast
Clinical assessment of patient ...... ata of nine randomised trials.
@en
Clinical assessment of patient ...... ata of nine randomised trials.
@nl
type
label
Clinical assessment of patient ...... ata of nine randomised trials.
@ast
Clinical assessment of patient ...... ata of nine randomised trials.
@en
Clinical assessment of patient ...... ata of nine randomised trials.
@nl
prefLabel
Clinical assessment of patient ...... ata of nine randomised trials.
@ast
Clinical assessment of patient ...... ata of nine randomised trials.
@en
Clinical assessment of patient ...... ata of nine randomised trials.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Clinical assessment of patient ...... ata of nine randomised trials.
@en
P2093
P304
P31
P356
10.1016/J.EJCA.2009.12.013
P433
P478
P50
P577
P698
P921